Advertisement
Screener

UNIGENE LABORATORIES INC Stock-Based Compensation

UNIGENE LABORATORIES INC Stock-Based Compensation

UNIGENE LABORATORIES INC reported Stock-Based Compensation of $266.39 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2013-05-14

  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for the quarter ending 2013-03-31 was $266.39K, a 30.19% decline year-over-year.
  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for the quarter ending 2012-12-31 was $201.92K, a 276.05% increase year-over-year.
  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $9.00K, a 125.00% increase year-over-year.
  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $354.84K, a 4969.19% increase year-over-year.
  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for fiscal 2012 was $1.23M, a 5.05% decline from fiscal 2011.
  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for fiscal 2011 was $1.30M, a 19.35% increase from fiscal 2010.
  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for fiscal 2010 was $1.09M, a 76.64% increase from fiscal 2009.
  • UNIGENE LABORATORIES INC share-based payment arrangement, noncash expense for fiscal 2009 was $614.80K.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2013-03-31$266.39K
10-Q · filed 2013-05-14
$468.30K
derived: sum of 2 quarters · filed 2013-05-14
$477.30K
derived: sum of 3 quarters · filed 2013-05-14
$832.15K
derived: sum of 4 quarters · filed 2013-05-14
2012-12-31$201.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$210.92K
derived: sum of 2 quarters · filed 2013-03-15
$565.76K
derived: sum of 3 quarters · filed 2013-03-15
$1.23M
10-K · filed 2013-03-15
2012-09-30$9.00K
10-Q · filed 2013-01-31
$363.84K
derived: sum of 2 quarters · filed 2013-01-31
$1.03M
10-Q · filed 2013-01-31
$799.11K
derived: sum of 4 quarters · filed 2013-05-14
2012-06-30$354.84K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-01-31
$736.41K
10-Q/A · filed 2013-01-31
$790.11K
derived: sum of 3 quarters · filed 2013-05-14
$794.11K
derived: sum of 4 quarters · filed 2013-05-14
2012-03-31$381.57K
10-Q · filed 2013-05-14
$435.26K
derived: sum of 2 quarters · filed 2013-05-14
$439.26K
derived: sum of 3 quarters · filed 2013-05-14
$446.26K
derived: sum of 4 quarters · filed 2013-05-14
2011-12-31$53.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$57.69K
derived: sum of 2 quarters · filed 2013-03-15
$64.69K
derived: sum of 3 quarters · filed 2013-03-15
$1.30M
10-K · filed 2013-03-15
2011-09-30$4.00K
10-Q · filed 2013-01-31
$11.00K
derived: sum of 2 quarters · filed 2013-01-31
$1.24M
10-Q · filed 2013-01-31
$909.53K
derived: sum of 4 quarters · filed 2013-03-15
2011-06-30$7.00K
10-Q/A · filed 2013-01-31
$922.69K
10-Q/A · filed 2013-01-31
$905.53K
derived: sum of 3 quarters · filed 2013-03-15
$1.18M
derived: sum of 4 quarters · filed 2013-03-15
2011-03-31$668.33K
10-Q/A · filed 2013-01-31
$898.53K
derived: sum of 2 quarters · filed 2013-03-15
$1.17M
derived: sum of 3 quarters · filed 2013-03-15
2010-12-31$230.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$503.97K
derived: sum of 2 quarters · filed 2013-03-15
$1.09M
10-K · filed 2013-03-15
2010-09-30$273.77K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$855.81K
10-Q · filed 2011-11-09
2010-06-30$582.04K
10-Q · filed 2011-08-09
2009-12-31$614.80K
10-K/A · filed 2013-01-31